Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.

Autor: Tortosa-Carreres J; Laboratory Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain; Medicine Department, University of Valencia, Valencia 46010, Spain; Neuroimmunology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain. Electronic address: jorditc95@outlook.com., Cubas-Núñez L; Neuroimmunology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain. Electronic address: laura_cubas@iislafe.es., Quiroga-Varela A; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain., Castillo-Villalba J; Neuroimmunology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain., Ramió-Torrenta L; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain; Medical Sciences Department, University of Girona, Girona, Spain., Piqueras M; Laboratory Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain; Medicine Department, University of Valencia, Valencia 46010, Spain; Respiratory Infections, Health Research Institute La Fe (IISLAFE), Valencia, Spain., Gasqué-Rubio R; Medicine Department, University of Valencia, Valencia 46010, Spain; Neuroimmunology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain., Quintanilla-Bordas C; Neuroimmunology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain; Neurology Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain., Sanz MT; Department of Didactic of Mathematics, University of Valencia, Spain., Lucas C; Computer Systems, La Fe University and Polytechnic Hospital, Valencia 46026, Spain., Huertas-Pons JM; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain., Miguela A; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain., Casanova B; Neuroimmunology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain; Neurology Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain., Laiz-Marro B; Laboratory Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain., Pérez-Miralles FC; Neuroimmunology Unit, Health Research Institute La Fe (IISLAFE), Valencia, Spain; Neurology Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Aug; Vol. 88, pp. 105734. Date of Electronic Publication: 2024 Jun 17.

Reconstruction of the ulnar artery in Guyon's canal with an arterial graft: Anatomical study.

Autor: Bordas C; Department of Hand Surgery, Plastic and Reconstructive Surgery, Centre Chirurgical Emile Gallé, CHU Nancy, France. Electronic address: coraliebordas26@gmail.com., Piessat C; Department of Hand Surgery, Plastic and Reconstructive Surgery, Centre Chirurgical Emile Gallé, CHU Nancy, France., Perez M; Faculty of Medicine and University Hospital, Department of Anatomy, University of Lorraine, Nancy, France., Gondim Teixeira PA; Guilloz Imaging Center, Nancy University Hospital, 29 Avenue du Maréchal-de-Lattre-de-Tassigny, 54000 Nancy, France., Dap F; Department of Hand Surgery, Plastic and Reconstructive Surgery, Centre Chirurgical Emile Gallé, CHU Nancy, France., Athlani L; Department of Hand Surgery, Plastic and Reconstructive Surgery, Centre Chirurgical Emile Gallé, CHU Nancy, France.

Publikováno v: Hand surgery & rehabilitation [Hand Surg Rehabil] 2024 Feb; Vol. 43 (1), pp. 101617. Date of Electronic Publication: 2023 Nov 10.

21091. ESTUDIO COMPARATIVO DEL RIESGO DE ACTIVIDAD EN ESCLEROSIS MÚLTIPLE TRAS EL CAMBIO DE MODULADORES DEL RECEPTOR DE LA ESFINGOSINA 1-FOSFATO A ANTI-CD20

Autor: Cervera Ygual, G., Benavent Giménez, M., Quintanilla Bordás, C., Carcelén Gadea, M., Navarro Cantó, L., Domínguez Morán, J., Alcalá Vicente, C., López Arqueros, J., Pérez Miralles, F., Sánchez Villanueva, E., Casanova Estruch, B., Gascón Giménez, F.

Publikováno v: In Neurology Perspectives November 2024 4 Supplement 1:212-212

Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm.

Autor: Tortosa-Carreres J; Laboratory Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain; Medicine Department, University of Valencia, Valencia 46010, Spain. Electronic address: jorditc95@outlook.com., Quiroga-Varela A; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Castillo-Villalba J; Grupo de investigación en Neuroinmunología, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, España; Medicine Department, University of Valencia, Valencia 46010, Spain., Piqueras-Rodríguez M; Laboratory Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain; Medicine Department, University of Valencia, Valencia 46010, Spain., Ramió-Torrenta L; Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain; Medical Sciences Department, University of Girona, Girona, Spain., Cubas-Núñez L; Grupo de investigación en Neuroinmunología, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, España., Gasqué-Rubio R; Grupo de investigación en Neuroinmunología, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, España; Medicine Department, University of Valencia, Valencia 46010, Spain., Quintanilla-Bordas C; Neurology Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain; Grupo de investigación en Neuroinmunología, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, España., Huertas-Pons JM; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Miguela A; Neurodegeneration and Neuroinflammation Research Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Casanova B; Neurology Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain; Grupo de investigación en Neuroinmunología, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, España., Laiz-Marro B; Laboratory Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain., Pérez-Miralles FC; Neurology Department, La Fe University and Polytechnic Hospital, Valencia 46026, Spain; Grupo de investigación en Neuroinmunología, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, España.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2023 Nov; Vol. 79, pp. 104997. Date of Electronic Publication: 2023 Sep 09.